Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging
暂无分享,去创建一个
[1] Adrian V. Lee,et al. Altered mammary gland development in the p53+/m mouse, a model of accelerated aging. , 2008, Developmental biology.
[2] L. Donehower,et al. Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity , 2007, Mechanisms of Ageing and Development.
[3] A. Levine,et al. Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations , 2007, Proceedings of the National Academy of Sciences.
[4] J. Campisi,et al. Two faces of p53: aging and tumor suppression , 2007, Nucleic acids research.
[5] Ronald A. DePinho,et al. How stem cells age and why this makes us grow old , 2007, Nature Reviews Molecular Cell Biology.
[6] M. Blasco,et al. Cancer and ageing: convergent and divergent mechanisms , 2007, Nature Reviews Molecular Cell Biology.
[7] Chad A Shaw,et al. Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation , 2007, PLoS biology.
[8] L. Donehower,et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. , 2007, Blood.
[9] M. Turker,et al. Age‐related accumulation of autosomal mutations in solid tissues of the mouse is gender and cell type specific , 2007, Aging cell.
[10] J. Hoeijmakers,et al. Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome , 2006, PLoS biology.
[11] J. Hoeijmakers,et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis , 2006, Nature.
[12] Jiri Bartek,et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin , 2006, Aging cell.
[13] K. Ligon,et al. p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.
[14] R. DePinho,et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.
[15] S. Morrison,et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.
[16] S. Sommer,et al. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype. , 2006, Carcinogenesis.
[17] T. Prolla,et al. Mitochondrial DNA mutations and apoptosis in mammalian aging. , 2006, Cancer research.
[18] P. Kirkpatrick,et al. Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress , 2006, Circulation research.
[19] T. Rando. Stem cells, ageing and the quest for immortality , 2006, Nature.
[20] J. Vijg,et al. Maintaining genetic integrity in aging: a zero sum game. , 2006, Antioxidants & redox signaling.
[21] S. Venkatachalam. Aging, p53 and the ‘24 gene mutant’: getting it right A reply to Vijg and Hasty , 2005, Aging cell.
[22] P. Hasty,et al. Aging and p53: getting it straight A commentary on a recent paper by Gentry and Venkatachalam , 2005, Aging cell.
[23] W. Deppert,et al. Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.
[24] S. Helfand,et al. Neuronal Expression of p53 Dominant-Negative Proteins in Adult Drosophila melanogaster Extends Life Span , 2005, Current Biology.
[25] Ignacio Varela,et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.
[26] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[27] S. Venkatachalam,et al. Complicating the role of p53 in aging , 2005, Aging cell.
[28] Bernd W. Brandt,et al. Variation in the human TP53 gene affects old age survival and cancer mortality1 , 2005, Experimental Gerontology.
[29] J. Campisi. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.
[30] T. Kirkwood,et al. Understanding the Odd Science of Aging , 2005, Cell.
[31] P. Hasty. The impact of DNA damage, genetic mutation and cellular responses on cancer prevention, longevity and aging: observations in humans and mice , 2005, Mechanisms of Ageing and Development.
[32] L. Donehower,et al. p53 and Mouse Aging Models , 2005 .
[33] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[34] N. Sharpless,et al. Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.
[35] K. Mohammad,et al. Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.
[36] S. Sommer,et al. Spontaneous mutation in Big Blue® mice from fetus to old age: Tissue‐specific time courses of mutation frequency but similar mutation types , 2004, Environmental and molecular mutagenesis.
[37] Sam W. Lee,et al. Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions , 2003, Molecular and Cellular Biology.
[38] Yingpei Zhang,et al. Caspases, apoptosis and aging , 2003, Ageing Research Reviews.
[39] Judith Campisi,et al. Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.
[40] J. Hoeijmakers,et al. Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.
[41] C. Deng,et al. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. , 2003, Genes & development.
[42] Martin Holzenberger,et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.
[43] P. Klatt,et al. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally , 2002, The EMBO journal.
[44] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[45] L. Donehower. Does p53 affect organismal aging? , 2002, Journal of cellular physiology.
[46] Y. Suh. Cell signaling in aging and apoptosis , 2002, Mechanisms of Ageing and Development.
[47] J. Hoeijmakers,et al. Premature Aging in Mice Deficient in DNA Repair and Transcription , 2002, Science.
[48] D. Dunson,et al. Mutational fingerprints of aging. , 2002, Nucleic acids research.
[49] Stephen N. Jones,et al. p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.
[50] S. Shack,et al. Loss in oxidative stress tolerance with aging linked to reduced extracellular signal‐regulated kinase and Akt kinase activities , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] V. Paradis,et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. , 2001, Human pathology.
[52] D. Kurz,et al. Cellular Senescence After Single and Repeated Balloon Catheter Denudations of Rabbit Carotid Arteries , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[53] George C. Williams,et al. PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.
[54] Steven N. Austad,et al. Why do we age? , 2000, Nature.
[55] J Vijg,et al. Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Benson,et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.
[57] H. Vogel,et al. Analysis of ku80-Mutant Mice and Cells with Deficient Levels of p53 , 2000, Molecular and Cellular Biology.
[58] Y. Higami,et al. Apoptosis in the aging process , 2000, Cell and Tissue Research.
[59] G. R. Stuart,et al. Mutation frequency and specificity with age in liver, bladder and brain of lacI transgenic mice. , 2000, Genetics.
[60] Y. Hosoi,et al. Age-associated increase of spontaneous mutant frequency and molecular nature of mutation in newborn and old lacZ-transgenic mouse. , 2000, Mutation research.
[61] Pier Paolo Pandolfi,et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.
[62] H. Vogel,et al. Deletion of Ku86 causes early onset of senescence in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[63] Lynda Chin,et al. p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.
[64] Sandy Chang,et al. Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice , 1999, Cell.
[65] W. Horton,et al. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals , 1998, The Anatomical record.
[66] A. Balmain,et al. The p53 response to ionising radiation in adult and developing murine tissues. , 1996, Oncogene.
[67] G. Hannon,et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Haavik,et al. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. , 1995, Oncogene.
[69] T. Ide,et al. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. , 1995, Oncogene.
[70] L. Donehower,et al. Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice , 1993, Nature Genetics.
[71] L. Donehower,et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.
[72] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[73] Edward L. Schneider,et al. Handbook of the Biology of Aging , 1990 .